• Featured Product
  • KD/KO Validated

BCL6 Polyklonaler Antikörper

BCL6 Polyklonal Antikörper für FC, IHC, IP, WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human und mehr (1)

Anwendung

WB, IP, IHC, FC, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 21187-1-AP

Synonyme

B cell CLL/lymphoma 6, B cell lymphoma 5 protein, B cell lymphoma 6 protein, BCL6, LAZ3, Protein LAZ 3, ZBTB27, Zinc finger protein 51, ZNF51



Geprüfte Anwendungen

Erfolgreiche Detektion in WBRaji-Zellen
Erfolgreiche IPRaji-Zellen
Erfolgreiche Detektion in IHChumanes Tonsillitisgewebe, humanes Lymphomgewebe
Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:500-1:3000
Immunpräzipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunhistochemie (IHC)IHC : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

21187-1-AP bindet in WB, IP, IHC, FC, ELISA BCL6 und zeigt Reaktivität mit human

Getestete Reaktivität human
In Publikationen genannte Reaktivitäthuman, Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen BCL6 fusion protein Ag15519
Vollständiger Name B-cell CLL/lymphoma 6
Berechnetes Molekulargewicht 706 aa, 79 kDa
Beobachtetes Molekulargewicht 79-95 kDa
GenBank-ZugangsnummerBC150184
Gene symbol BCL6
Gene ID (NCBI) 604
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

BCl6, a zinc finger transcription factor, contains a N-terminal BTB/POZ domain and C-terminal zinc finger DNA-binding motifs and represses transcription of a wide range of target proteins and microRNAs. BCL6 protein has been reported as a master regulator of B lymphocyte development and growth, and altered BCL6 protein expression was implicated in pathogenesis of diverse human hematologic malignancies, especially in the diffuse large B cell lymphoma (DLBCL). BCL6 is required for the development of T follicular helper T cells (TFH), a helper T cell subset required for the formation of mature and productive GCs. BCL6 has also been shown to play important regulatory roles in macrophages.

Protokolle

Produktspezifische Protokolle
WB protocol for BCL6 antibody 21187-1-APProtokoll herunterladen
IHC protocol for BCL6 antibody 21187-1-APProtokoll herunterladen
IP protocol for BCL6 antibody 21187-1-APProtokoll herunterladen
Standard-Protokolle
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
IHC

Nat Commun

A truncating mutation in the autophagy gene UVRAG drives inflammation and tumorigenesis in mice.

Authors - Christine Quach
humanWB

Respir Res

Transcriptional inhibition of miR-486-3p by BCL6 upregulates Snail and induces epithelial-mesenchymal transition during radiation-induced pulmonary fibrosis.

Authors - Ziyan Yan
mouseWB

Sci Rep

Specific immunotherapy in combination with Clostridium butyricum inhibits allergic inflammation in the mouse intestine.

Authors - Yanhong Shi
humanWB,IP

Front Cell Dev Biol

Development of a contacting transwell co-culture system for the in vitro propagation of primary central nervous system lymphoma

Authors - Mayuko Nishi
humanIHC

Front Cell Dev Biol

The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Colon Adenocarcinoma Metastasis.

Authors - Zhengyan Chang
humanIHC

Front Oncol

Whole-Exome Sequencing Reveals New Potential Mutations Genes for Primary Mucosa-Associated Lymphoid Tissue Lymphoma Arising From the Kidney.

Authors - Shuang Wen